Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Adcetris
Adcetris
Seattle Genetics Makes Case for Expanded Use of Adcetris as Lymphoma Maintenance Therapy
The Street
Sun, 12/7/14 - 10:09 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting
Yahoo/BusinessWire
Sat, 12/6/14 - 11:15 am
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win
TheStreet.com
Mon, 09/29/14 - 10:16 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Progenics Likely To Announce Positive Prostate Cancer Data In January
Seeking Alpha
Tue, 01/7/14 - 09:28 am
prostate cancer
Progenics
Celldex Therapeutics
Seattle Genetics
CytRx
Adcetris
Weighing Out The Seattle Genetics Barbell
Seeking Alpha
Fri, 12/27/13 - 01:03 pm
Seattle Genetics
antibody-drug conjugate
Adcetris
Four Biotech 'Surprise' Stocks for 2014
TheStreet.com
Wed, 11/27/13 - 08:34 am
Seattle Genetics
Adcetris
Cubist Pharmaceuticals
Cempra
Eylea
Regeneron
Pharmacyclics
Imbruvica
Gilead
sofosbuvir
Is Seattle Genetics an Acquisition Target?
Motley Fool
Tue, 09/10/13 - 10:26 am
M&A
Seattle Genetics
Adcetris
Bayer
AbbVie
Genentech
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
Safety Concern Halts Study of Seattle Genetics' Lymphoma Drug
TheStreet.com
Tue, 06/25/13 - 12:19 pm
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Seattle Genetics highlights ADCETRIS data at lymphoma conference
Yahoo/Fly on the Wall
Fri, 06/21/13 - 09:14 am
Seattle Genetics
Adcetris
lymphoma
Seattle Genetics Highlights Adcetris (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/2/13 - 11:43 am
Seattle Genetics
Adcetris
T-cell lymphoma
systemic anaplastic large cell lymphoma
Hodgkin's lymphoma
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
Biotech Corner: Monoclonal Antibody Companies
Seeking Alpha
Wed, 12/12/12 - 10:19 am
monoclonal antibodies
Adcetris
Seattle Genetics
Progenics
Seattle Genetics to test possible new Adcetris use in late-stage study
Yahoo/AP
Mon, 12/10/12 - 12:04 pm
Seattle Genetics
Adcetris
non-Hodgkin's lymphoma
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/9/12 - 01:17 pm
Seattle Genetics
Adcetris
non-Hodgkin's lymphoma
Takeda and Millennium Announce Positive CHMP Opinion for Conditional Approval of Adcetris in Europe
Enhanced Online News
Sat, 07/21/12 - 12:11 pm
Adcetris
Takeda
Millennium
Seattle Genetics CEO Siegall Sees Many Uses for Cancer Drug
Minyanville
Fri, 06/15/12 - 11:05 am
Seattle Genetics
Clay Siegall
Adcetris
Seattle Genetics updates survival data from Adcetris trial for Hodkin lymphoma
Yahoo/Fly on the Wall
Thu, 06/14/12 - 11:14 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Fri, 06/1/12 - 12:28 pm
ASCO
antibody-drug conjugate
Roche
Genentech
Immunogen
T-DM1
Adcetris
Seattle Genetics
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Pages
« first
‹ previous
1
2
3
4
next ›
last »